Latest receivables for COV.V: $4.6M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest receivables for COV.V is $4.6M as of June 2026. That compares with $4.7M in the prior-year period — down 2.9% year over year. Investors often review this figure alongside Covalon Technologies's historical trend and sector peers before judging valuation or financial health.
Over the past year, COV.V's receivables moved from $4.7M to $4.6M — a 2.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Covalon Technologies's operating scale or balance-sheet position.
A receivables figure of $4.6M for COV.V is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting COV.V's receivables ($4.6M), review year-over-year change from $4.7M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.